Skip to Content

Carl Zeiss Meditec AG AFX

Morningstar Rating
€98.70 +1.35 (1.39%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

AFX is trading at a 19% premium.
Price
€97.35
Fair Value
€23.00
Uncertainty
Medium
1-Star Price
€576.90
5-Star Price
€21.30
Economic Moat
Wgmwv
Capital Allocation
Dvgngcg

Bulls Say, Bears Say

Bulls

Favorable industrywide trends, such as the aging population, an increasing prevalence of myopia, and a growing access to advanced healthcare across the globe, will act as tailwinds for Zeiss.

Bears

The US represents Zeiss’ second-largest market and the company’s limited portfolio of intraocular lenses and a weak presence in the surgical space in the region is further threatened by its competitors.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AFX is a good fit for your portfolio.

Trading Information

Previous Close Price
€97.35
Day Range
€97.2099.75
52-Week Range
€72.60123.75
Bid/Ask
€98.70 / €98.80
Market Cap
€8.81 Bil
Volume/Avg
66,857 / 131,627

Key Statistics

Price/Earnings (Normalized)
30.92
Price/Sales
4.23
Dividend Yield (Trailing)
1.13%
Dividend Yield (Forward)
1.13%
Total Yield
1.13%

Company Profile

Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Growth
Total Number of Employees
4,823

Competitors

Valuation

Metric
AFX
JNJ
Price/Earnings (Normalized)
30.9214.45
Price/Book Value
4.105.20
Price/Sales
4.234.24
Price/Cash Flow
23.5316.34
Price/Earnings
AFX
JNJ

Financial Strength

Metric
AFX
JNJ
Quick Ratio
2.410.84
Current Ratio
3.401.17
Interest Coverage
22.0523.57
Quick Ratio
AFX
JNJ

Profitability

Metric
AFX
JNJ
Return on Assets (Normalized)
12.64%
Return on Equity (Normalized)
31.72%
Return on Invested Capital (Normalized)
20.11%
Return on Assets
AFX
JNJ
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncQnkvkndssJdtjy$131.8 Bil
BDX
Becton Dickinson & CoDpqtrfpwBhxcm$69.5 Bil
ALC
Alcon IncYxqlcykkvSbmsdyp$38.1 Bil
RMD
ResMed IncNtkxgwtjqKfmfl$31.6 Bil
CLPBY
Coloplast A/S ADRWqjhxylwYjwpf$27.2 Bil
WST
West Pharmaceutical Services IncMcxpscjycWmpp$27.0 Bil
BAX
Baxter International IncCymykksyHxpnqgy$20.5 Bil
COO
The Cooper Companies IncTxjhrncqWdtbr$17.8 Bil
HOLX
Hologic IncXtlbvbnvDjkwdb$17.8 Bil
ATR
AptarGroup IncVgdyvxzmGkkhtm$9.7 Bil

Sponsor Center